The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt‐based anti‐cancer drugs
Open accessAbstract
Although platinum-based drugs are widely used chemotherapeutics for cancer treatment, the determinants of tumor cell responsiveness remain poorly understood. We show that the loss of subunits LRRC8A and LRRC8D of the heteromeric LRRC8 volume-regulated anion channels (VRACs) increased resistance to clinically relevant cisplatin/carboplatin concentrations. Under isotonic conditions, about 50% of cisplatin uptake depended on LRRC8A and LRRC8D, but neither on LRRC8C nor on LRRC8E. Cell swelling strongly enhanced LRRC8-dependent cisplatin uptake, bolstering the notion that cisplatin enters cells through VRAC. LRRC8A disruption also suppressed drug-induced apoptosis independently from drug uptake, possibly by impairing VRAC-dependent apoptotic cell volume decrease. Hence, by mediating cisplatin uptake and facilitating apoptosis, VRAC plays a dual role in the cellular drug response. Incorporation of the LRRC8D subunit into VRAC substantially increased its permeability for cisplatin and the cellular osmolyte taurine, indicating that LRRC8 proteins form the channel pore. Our work suggests that LRRC8D-containing VRACs are crucial for cell volume regulation by an important organic osmolyte and may influence cisplatin/carboplatin responsiveness of tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Whole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
The role of apoptosis in cancer development and treatment response
Brown, J. M., & Attardi, L. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1560 · Cited by 944
Maeno, E., Ishizaki, Y., Kanaseki, T., Hazama, A., & Okada, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140216197 · Cited by 707
Okada, Y. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.3.c755 · Cited by 652
Voss, F. K., Ullrich, F., Münch, J., Lazarow, K., Lutter, D., Mah, N., Andrade-Navarro, M. A., von Kries, J. P., Stauber, T., & Jentsch, T. J. (2014) · Science · doi:10.1126/science.1252826 · Cited by 619
Self-citationCellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
Qiu, Z., Dubin, A. E., Mathur, J., Tu, B., Reddy, K., Miraglia, L. J., Reinhardt, J., Orth, A. P., & Patapoutian, A. (2014) · Cell · doi:10.1016/j.cell.2014.03.024 · Cited by 571
Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling
Mandic, A., Hansson, J., Linder, S., & Shoshan, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210284200 · Cited by 509
Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens
Carette, J. E., Guimaraes, C. P., Varadarajan, M., Park, A. S., Wuethrich, I., Godarova, A., Kotecki, M., Cochran, B. H., Spooner, E., Ploegh, H. L., et al. (2009) · Science · doi:10.1126/science.1178955 · Cited by 489
Self-citationSearching for SNPs with cloud computing
Langmead, B., Schatz, M. C., Lin, J., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-11-r134 · Cited by 484
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
Hall, M. D., Okabe, M., Shen, D.-W., Liang, X.-J., & Gottesman, M. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.080907.180426 · Cited by 474
Green fluorescent protein‐based halide indicators with improved chloride and iodide affinities
Galietta, L. J. V., Haggie, P. M., & Verkman, A. S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02561-3 · Cited by 371
Physiological role of taurine – from organism to organelle
Lambert, I. H., Kristensen, D. M., Holm, J. B., & Mortensen, O. H. (2015) · Acta Physiologica · doi:10.1111/apha.12365 · Cited by 360
Properties of volume-regulated anion channels in mammalian cells
Nilius, B., Eggermont, J., Voets, T., Buyse, G., Manolopoulos, V., & Droogmans, G. (1997) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(97)00021-7 · Cited by 360
Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux
Jackson, P. S., & Strange, K. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.6.c1489 · Cited by 338
A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl-channel
Shimizu, T., Numata, T., & Okada, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401604101 · Cited by 237
Drug transporters of platinum-based anticancer agents and their clinical significance
Burger, H., Loos, W. J., Eechoute, K., Verweij, J., Mathijssen, R. H. J., & Wiemer, E. A. C. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.002 · Cited by 230
Volume-sensitive Chloride Channels Involved in Apoptotic Volume Decrease and Cell Death
Okada, Y., Shimizu, T., Maeno, E., Tanabe, S., Wang, X., & Takahashi, N. (2006) · Journal of Membrane Biology · doi:10.1007/s00232-005-0836-6 · Cited by 227
Global gene disruption in human cells to assign genes to phenotypes by deep sequencing
Carette, J. E., Guimaraes, C. P., Wuethrich, I., Blomen, V. A., Varadarajan, M., Sun, C., Bell, G., Yuan, B., Muellner, M. K., Nijman, S. M., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1857 · Cited by 223
Self-citationBerndtsson, M., Hägg, M., Panaretakis, T., Havelka, A. M., Shoshan, M. C., & Linder, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22132 · Cited by 215
How do real tumors become resistant to cisplatin?
Borst, P., Rottenberg, S., & Jonkers, J. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5930 · Cited by 192
Self-citationRole of Ion Transport in Control of Apoptotic Cell Death
Lang, F. J. W., & Hoffmann, E. K. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110046 · Cited by 179
Abascal, F., & Zardoya, R. (2012) · BioEssays · doi:10.1002/bies.201100173 · Cited by 169
Varela, D., Simón, F., Riveros, A. L., Jørgensen, F., & Stutzin, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400020200 · Cited by 168
Hyzinski‐García, M. C., Rudkouskaya, A., & Mongin, A. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.278887 · Cited by 137
Poulsen, K. A., Andersen, E. C., Hansen, C. F., Klausen, T. K., Hougaard, C. Ø., Lambert, I. H., & Hoffmann, E. K. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00654.2008 · Cited by 125
Brown, J. M., & Wilson, G. D. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.450 · Cited by 119
Pharmacological “cross‐inhibition” of connexin hemichannels and swelling activated anion channels
Ye, Z., Oberheim, N., Kettenmann, H., & Ransom, B. R. (2008) · Glia · doi:10.1002/glia.20754 · Cited by 116
Ion channels and transporters in the development of drug resistance in cancer cells
Hoffmann, E. K., & Lambert, I. H. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0109 · Cited by 116
The identification of a volume‐regulated anion channel: an amazingOdyssey
Pedersen, S. F., Klausen, T. K., & Nilius, B. (2015) · Acta Physiologica · doi:10.1111/apha.12450 · Cited by 115
Cell swelling activates separate taurine and chloride channels in Ehrlich mouse ascites tumor cells
Lambert, I. H., & Hoffmann, E. K. (1994) · The Journal of Membrane Biology · doi:10.1007/bf00233436 · Cited by 112
The Essential Role of Evasion from Cell Death in Cancer
Kelly, G. L., & Strasser, A. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-385524-4.00002-7 · Cited by 111
Separate taurine and chloride efflux pathways activated during regulatory volume decrease
Stutzin, A., Torres, R., Oporto, M., Pacheco, P. A., Eguiguren, A. L., Cid, L. P., & Sepúlveda, F. V. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c392 · Cited by 95
Fischer, S. J., Benson, L. M., Fauq, A. H., et al. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.010 · Cited by 89
Ivy, K. D., & Kaplan, J. H. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085068 · Cited by 85
Lee, C. C., Freinkman, E., Sabatini, D. M., & Ploegh, H. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.571257 · Cited by 81
Lee, E. L., Shimizu, T., Ise, T., Numata, T., Kohno, K., & Okada, Y. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20961 · Cited by 78
Sørensen, B. H., Thorsteinsdottir, U. A., & Lambert, I. H. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00274.2014 · Cited by 74
Sizing the pore of the volume‐sensitive anion channel by differential polymer partitioning
Ternovsky, V. I., Okada, Y., & Sabirov, R. Z. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.051 · Cited by 65
SHENNAN, D. B. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000113743 · Cited by 65
Droogmans, G., Maertens, C., Prenen, J., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702770 · Cited by 64
Ise, T., Shimizu, T., Lee, E. L., Inoue, H., Kohno, K., & Okada, Y. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0779-y · Cited by 58
de Tassigny, A. D., Berdeaux, A., Souktani, R., Henry, P., & Ghaleh, B. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.11.002 · Cited by 57
Orlov, S. N., Platonova, A., Hamet, P., & Grygorczyk, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00040.2013 · Cited by 52
Min, X., Li, H., Hou, S., He, W. W., Liu, J., Hu, B., & Wang, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010297 · Cited by 48
Harnessing the cell death pathway for targeted cancer treatment.
Speirs, C. K., Hwang, M., Kim, S., Li, W., Chang, S., Varki, V., Mitchell, L., Schleicher, S. M., & Lu, B. (2011) · Europe PMC (PubMed Central) · Cited by 46
Does resistance to apoptosis affect clinical response to antitumor drugs?
Borst, P., Borst, J. G., & Smets, L. A. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0187 · Cited by 41
Self-citationFayad, W., Brnjic, S., Berglind, D., Blixt, S., Shoshan, M. C., Berndtsson, M., Olofsson, M. H., & Linder, S. T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24627 · Cited by 38
Holm, J. B., Grygorczyk, R., & Lambert, I. H. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00412.2012 · Cited by 27
Harnessing the cell death pathway for targeted cancer treatment
Speirs, C. K., Hwang, M., Kim, S., Li, W., Chang, S., Varki, V., Mitchell, L., Schleicher, S., & Lu, B. (2010) · Europe PMC (PubMed Central) · Cited by 22
Cited by
The rediscovery of platinum-based cancer therapy
Rottenberg, S., Disler, C., & Perego, P. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00308-y · Cited by 972
Self-citationPlatinum-based drugs: past, present and future
Dilruba, S., & Kalayda, G. V. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2976-z · Cited by 906
Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?
Prevarskaya, N., Skryma, R., & Shuba, Y. (2018) · Physiological Reviews · doi:10.1152/physrev.00044.2016 · Cited by 484
CLC Chloride Channels and Transporters: Structure, Function, Physiology, and Disease
Jentsch, T. J., & Pusch, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00047.2017 · Cited by 448
Self-citationVRACs and other ion channels and transporters in the regulation of cell volume and beyond
Jentsch, T. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.29 · Cited by 353
Self-citation
Metadata
- Authors
- Planells‐Cases, R., Lutter, D., Guyader, C., Gerhards, N. M., Ullrich, F., Elger, D. A., Kucukosmanoglu, A., Xu, G., Voss, F. K., Reincke, S. M., Stauber, T., Blomen, V. A., Vis, D. J., Wessels, L. F., Brummelkamp, T. R., Borst, P., Rottenberg, S., & Jentsch, T. J.
- Venue
- The EMBO Journal
- Published
- 2015-11-03
- Volume
- 34
- Issue
- 24
- Pages
- 2993-3008
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2126297765
- Cited by
- 256
- References
- 51
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.